TOI logo
The Oncology Institute, Inc.(TOI)
Last print unknown agoAbout this dataData status
$5.13▼-1.26 (-19.72%)Stale · unknown old

TOI EBITDA Growth

54.77%TTM

Period ending:

TOI TTM EBITDA YoY %%
TOI TTM EBITDA YoY %1732.90%-4325.28%
2021-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

TOI ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 20 observations from Sep 30, 2021 to Jun 30, 2026.

Oncology Institute Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
54.7684%
37.4079%
16.4367%
10.1699%
10.9625%
16.5815%
6.288%
1.301%
-26.2199%
-65.7821%
-3,739.008%
-1,327.461%
-1,401.2712%
-370.3443%
118.798%
1,146.62%
257.9395%
731.5666%
-102.5087%
-127.2583%

Compare ebitda growth

All TOI financial metrics · TOI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.